Apricus Biosciences Competitors and Similar CompaniesClear all
Apricus Biosciences's competitors and similar companies include BioMarin Pharmaceutical, CSL Behring, Fujifilm Diosynth Biotechnologies and Chiesi Group.
 Apricus Biosciences Apricus Biosciences is a pharmaceutical company that develops and markets innovative treatments for sexual health. |  BioMarin Pharmaceutical BioMarin develops and provides innovative biopharmaceuticals for serious diseases and medical conditions. |  Fujifilm Diosynth Biotechnologies Fujifilm Diosynth Biotechnologies U.S.A. is a contract development and manufacturing organization operating in the biopharmaceutical industry. |  Chiesi Group Chiesi Group (Gruppo Chiesi, also known as CHIESI Farmaceutici) is a company that researches, develops, produces, and commercializes therapeutic solutions. | ||
Founding Date | Founding Date 1987 | Founding Date 1997 | Founding Date 1904 | Founding Date 2011 | Founding Date 1935 |
Type | Type Public | Type Public | Type Subsidiary | Type Subsidiary | Type Subsidiary |
Tags | |||||
Locations | Locations San Diego, US HQ | Locations San Rafael, US HQ Martínez, AR Crows Nest, AU Sao Paulo, BR Bogotá, CO Kronberg Im Taunus, DE Wanchai, HK see more | Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more | Locations Morrisville, US HQ Hillerød, DK Stockton On Tees, GB College Station, US | Locations Parma, IT HQ Melbourne, AU Wien, AT Machelen, BE Santana De Parnaíba, BR São Paulo, BR Sofia, BG see more |
Employees | Employees 15 | Employees 3,0015% increase | Employees 7,5692% decrease | Employees 5,3942% increase | Employees 5,8541% increase |
Valuation ($) | Valuation ($) 6.2 m | Valuation ($) 13.3 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $3.2b (FY, 2025) | Revenue (est.) $7.9b (FY, 2020) | Revenue (est.) N/A | Revenue (est.) €2.4b (Y, 2021) |
Gross profit | Gross profit N/A | Gross profit $2.5b (FY, 2025) | Gross profit $4.5b (FY, 2020) | Gross profit N/A | Gross profit N/A |
Net income | Net income ($66m) (FY, 2021) | Net income $348.9m (FY, 2025) | Net income N/A | Net income N/A | Net income N/A |
Operating ⚠ | |||||
Patent Applications | Patent Applications N/A | Patent Applications 426 (FY, 2016) | Patent Applications 3 (Dec, 2020) | Patent Applications N/A | Patent Applications N/A |
Funding | |||||
Total funding raised | Total funding raised $ 12.3m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 850m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
BioMarin Pharmaceutical
HQ
San Rafael, US
Employees
3,001↑ 5% increase
BioMarin develops and provides innovative biopharmaceuticals for serious diseases and medical conditions.
View companyFujifilm Diosynth Biotechnologies
HQ
Morrisville, US
Fujifilm Diosynth Biotechnologies U.S.A. is a contract development and manufacturing organization operating in the biopharmaceutical industry.
View companyChiesi Group
HQ
Parma, IT
Chiesi Group (Gruppo Chiesi, also known as CHIESI Farmaceutici) is a company that researches, develops, produces, and commercializes therapeutic solutions.
View company